|
Exact Sciences Corporation - Company Profile Snapshot
| Company Profile: |
Exact Sciences Corporation |
| Ticker: |
EXAS |
| Exchanges: |
NAS |
| 2008 Sales: |
1,367,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED STATES |
| Employees: |
4 |
Business Description
Exact Sciences Corporation. The Group's principal activities are to develop and commercialize proprietary DNA based tests for the early detection of cancer and other types of common cancers. PreGen-Plus utilizes PreGen technologies to isolate the minute amounts of human DNA shed from the colon into stool and then identifies mutations in DNA shed from abnormal cells indicative of colorectal cancer and pre-cancerous lesions. It also offers PreGen-Plus through LabCorp, in the United States with 35 primary laboratories and over 1,600 patient service centers. LabCorp is the exclusive licensee, in the United States and Canada, of the technology that surrounds PreGen-Plus.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
